Principal Financial Group Inc Quanterix Corp Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$12.26 - $23.78 $29,755 - $57,714	-2,427 Reduced 9.05%	24,397 $322,000
Q1 2024 Apr 29, 2024	BUY	$21.9 - $28.28 $348,407 - $449,906	15,909 Added 145.75%	26,824 $631,000
Q4 2023 Feb 07, 2024	SELL	$19.54 - $28.66 $18,895 - $27,714	-967 Reduced 8.14%	10,915 $298,000
Q3 2023 Nov 02, 2023	BUY	$21.15 - $27.96 $31,323 - $41,408	1,481 Added 14.24%	11,882 $322,000
Q2 2023 Aug 07, 2023	BUY	$11.16 - $23.65 $2,232 - $4,730	200 Added 1.96%	10,401 $234,000
Q1 2023 May 09, 2023	BUY	$10.12 - $14.91 $103,234 - $152,096	10,201 New	10,201 $114,000
Q2 2022 Aug 10, 2022	SELL	$15.06 - $30.65 $264,905 - $539,133	-17,590 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$23.26 - $42.41 $286,098 - $521,642	-12,300 Reduced 41.15%	17,590 $513,000
Q4 2021 Feb 09, 2022	BUY	$37.54 - $57.51 $1.12 Million - $1.72 Million	29,890 New	29,890 $1.27 Million

155

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $436M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.